BioMarin Pharmaceuticals
BMRN
BMRN
414 hedge funds and large institutions have $14B invested in BioMarin Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 159 increasing their positions, 150 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
2% less funds holding
Funds holding: 422 → 414 (-8)
9% less capital invested
Capital invested by funds: $15.4B → $14B (-$1.35B)
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
Holders
414
Holding in Top 10
11
Calls
$90.6M
Puts
$95.7M
Top Buyers
| 1 | +$156M | |
| 2 | +$80.9M | |
| 3 | +$75.2M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$64.4M |
| 5 |
HM
HealthCor Management
New York
|
+$64.2M |
Top Sellers
| 1 | -$116M | |
| 2 | -$98.5M | |
| 3 | -$69.6M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$47.5M |
| 5 |
FAM
Fred Alger Management
New York
|
-$46.4M |